首頁 > 美迪醫(yī)訊 > Research Report on amoxicillin & clavulanic acid |
Research Report on amoxicillin & clavulanic acid 【?2008-08-12 發(fā)布?】 美迪醫(yī)訊
Research Report on amoxicillin & clavulanic acidPublisher: Orient Health Electronic Commercial(Beijing)co.,Ltd
Published: July 2006
Format: Hardcopy and Adobe PDF
Price: US$3,200
Contact: Mr.Humphrey
Tel.: 86-10-58110925 Fax: 86-10-58110918
E-mail: hhuang@medicexchange.com
Foreword
1 Sales analysis of finished drug in sample hospital
1.1 Growth rate in the past 5 years(Sales value etc.)
1.2 Sales analysis of finished drug for injection
1.3 Sales analysis of finished drug for oral
1.4 Demanded volume of bulk drug for key enterprise
1.5 Market forecast about domestic finished drug market
2 Export analysis of bulk drug
2.1 Change of import volume in the past few years
2.2 Domestic demand for bulk drug
Market Research Report on non-steroid antiinflammatory drugsPublisher: Orient Health Electronic Commercial(Beijing)co.,Ltd
Published: July 2006
Format: Hardcopy and Adobe PDF
Price: US$2,400
Contact: Mr.Humphrey
Tel.: 86-10-58110925 Fax: 86-10-58110918
E-mail: hhuang@medicexchange.com
Foreword
1 Application market of non-steroid antiinflammatory drugs
1.1 Epidemiology of rheumatoid arthritis
1.2 Use Rate of non-steroid antiinflammatory drugs
1.3 Categories of non-steroid antiinflammatory drugs
1.4 Breeds included in Catalogue of Drugs for Basic National Medical Insurance
1.5 Categories of non-prescription drug
2 Categories and action mechanism
2.1 Categories classified according to chemical structure
2.2 Categories classified according to action mechanism
2.3 Category of immunosuppressant
3 Market analysis of the past few years
3.1 Change trend(including sales value, share of different products etc.)
3.2 Analysis of hospital sales last year
3.3 Analysis of pharmacy sales last year
3.4 Indicative retail price of key products
4 Sales analysis of different categories
(including sales value, enterpsise share etc.)
4.1 acetic acid class
Diclofenac
4.2 propanoic acid class
Ibuprofen
4.3 COX-2 inhibitor
Rofecoxib
Celecoxib
4.4 Nonacid class
Nabumetone
Nimesulide
4.5 immunosuppressant
auranofin tablets
Leflunomide
4.6 Compound
4.7 salicylates
4.8 Oxiacams
Meloxicam
Lornoxicam
Piroxicam
4.9 Others
aminoglucose
Ossotide
5 Key enterprises
Beijing Novartis Pharma Ltd.
Italy Rotta Research Laboratorium SpA
Tianjin Smith Kline & French laboratories Ltd
UPJOHN PHARMACY CO.,LTD
Suzhou Changzheng Cinkate Pharmacy Company
Johnson & Johnson China (Shanghai) Ltd.
Hangzhou MSD Pharmaceutical Co. Ltd
Heilongjiang Jiangshi Pharmaceutical Company Limited
Boehringer Ingelheim microParts GmbH
本文關鍵字:
《美迪醫(yī)訊》歡迎您參與新聞投稿,業(yè)務咨詢: 美迪醫(yī)療網業(yè)務咨詢《上海醫(yī)療器械批發(fā)》產品推薦
|
合作支持:中華醫(yī)學會 | 中華醫(yī)院管理學會 | 國家食品藥品監(jiān)督管理家用護理器械商城 | 國藥勵展展覽有限責任公 | 醫(yī)學裝備協(xié)會 |
刊登廣告 | 友情鏈接 | 廣告代理商加盟 | 關于美迪 | 法律聲明 | 隱私保護 | 網站地圖 |
把美迪網放進收藏夾 把美迪醫(yī)療網介紹給我的朋友 給美迪醫(yī)療網留言
美迪醫(yī)療網廣告業(yè)務聯系:021-51601230 產品咨詢業(yè)務聯系:021-51601230 傳真:021-56532303 美迪醫(yī)療網業(yè)務咨詢 互聯網藥品信息服務許可證:(滬)-經營性-2009-0003 中華人民共和國電信與信息服務業(yè)務經營許可證:(滬)B2-20090029 滬ICP備14001091號-8 公安備案號 31010602000199 醫(yī)療器械經營許可證: 滬靜藥監(jiān)械經營許20210003號 第二類醫(yī)療器械經營備案憑證: 滬靜藥監(jiān)械經營備20220042號 營業(yè)執(zhí)照:統(tǒng)一社會信用代碼91310108676284138X互聯網藥品信息服務資格書:(滬)-非經營性-2023-0081 |